GlassScriptPhysician profile
Laura Davis
NPI 1558907006
$2,030.90
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,246 · 2022: $32.75 · 2023: $721 · 2024: $31.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galt Pharmaceuticals, LLC | $638.32 | 2023 | Oravig, Orphengesic Forte |
| Abbvie INC. | $430.73 | 2021-2023 | |
| Amarin Pharma, INC. | $150.10 | 2021 | |
| Glaxosmithkline, LLC. | $122.76 | 2021-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $113.10 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.10 | 2021 | |
| Lilly USA, LLC | $74.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $62.94 | 2021 | |
| Amgen INC. | $55.47 | 2021-2024 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.87 | 2021 | |
| Arbor Pharmaceuticals, INC. | $34.05 | 2021 | |
| Pfizer INC. | $32.78 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $32.19 | 2023 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $29.97 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $29.63 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2021 | |
| Eisai INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.